« Back to Record
Citation APA

Van Marcke, C., Helaers, R., De Leener, A., Merhi, A., Schoonjans, C. C., Ambroise, J., Galant, C., Delreé, P., Rothé, F., Bar, I., Khoury, E., Brouillard, P., Canon, J.-L., Vuylsteke, P., Machiels, J. P., Berlière, M., Limaye, N., Vikkula, M., & Duhoux, F. F. (2020). Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families. Breast cancer research, 22(1), 36. doi:10.1186/s13058-020-01273-y


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/307212

Van Marcke, C., Helaers, R., De Leener, A., Merhi, A., Schoonjans, C. C., Ambroise, J., Galant, C., Delreé, P., Rothé, F., Bar, I., Khoury, E., Brouillard, P., Canon, J.-L., Vuylsteke, P., Machiels, J. P., Berlière, M., Limaye, N., Vikkula, M., & Duhoux, F. F. (2020). Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families. Breast cancer research, 22(1), 36. doi:10.1186/s13058-020-01273-y